Andrey is an EVP of Science and Technology at Zephyr AI, a leading company in applying artificial intelligence (AI) to biotechnology and life sciences. With over 10 years of experience in this field, Andrey has a proven track record of driving transformative innovation and strategic growth in the industry. His mission is to explore the uncharted territories of science and technology, and leverage AI to transform how we approach medical research, drug discovery and development, and patient care. His expertise in translating complex scientific challenges into actionable strategies catalyzes the convergence of AI and life sciences to address critical issues in disease understanding and treatment development. With a deep understanding of the evolving biotech landscape, he has successfully harnessed cutting-edge technologies to advance personalized medicine and deliver breakthrough solutions to oncology patients.As a visionary leader, Andrey fosters a collaborative and innovative culture within organizations, building high-performing teams and empowering individuals to unleash their full potential. He is passionate about bridging the gap between scientific advancements and commercial success, combining his extensive knowledge of biotech trends, market dynamics, and competitive intelligence. He is dedicated to shaping the future of healthcare through strategic leadership, cutting-edge technology adoption, and impactful industry collaborations.